NCT00398411 · OUTCOME

Time to Occurrence of Fever >= 38°C

Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells · Source last updated 2015-06-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEAN
Unit: days
Interval / dispersion: Standard Deviation
Time frame: end of treatment (mean duration of treatment was 9.7 days; 10.2 days in moxifloxacin arm, 9.2 days in placebo arm)

Analysis population: intention to treat (ITT)

Groups in this outcome

Moxifloxacin

moxifloxacin 400 mg tablets once daily

Placebo

identical appearing placebo

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Moxifloxacin	34
Placebo	32

Reported measurements

Source class 1

Values in days · Interval/dispersion: Standard Deviation
Group	Value	Spread	Lower	Upper	Comment
Moxifloxacin	9.50	4.1	Not reported	Not reported	Not reported
Placebo	7.69	3.1	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
spread
4.1
value
9.50
group Id
OG001
spread
3.1
value
7.69

denoms

counts
group Id
OG000
value
34
group Id
OG001
value
32
units
Participants

dispersion Type

Standard Deviation

groups

description
moxifloxacin 400 mg tablets once daily
id
OG000
title
Moxifloxacin
description
identical appearing placebo
id
OG001
title
Placebo

param Type

MEAN

population Description

intention to treat (ITT)

reporting Status

POSTED

time Frame

end of treatment (mean duration of treatment was 9.7 days; 10.2 days in moxifloxacin arm, 9.2 days in placebo arm)

title

Time to Occurrence of Fever >= 38°C

type

SECONDARY

unit Of Measure

days

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice